the literature. We suspect that the frequency of aggressive fibromatosis in these patients, which may necessitate radical resection and even amputation, has been underreported. Its mechanism of development relative to NMC is not understood.
Methods

Cases Encountered in our Institution
A retrospective review of the Mayo Clinic Tissue Registry database was performed to identify all cases of NMC that were evaluated, reviewed, and/or treated at our institution. Patients who developed aggressive fibromatosis or in whom aggressive fibromatosis coexisted with NMC were identified. Patient demographic characteristics and clinical information were reviewed. Approval for this study was obtained from the Mayo Clinic Institutional Review Board.
To better understand the relationship between NMC and the development of aggressive fibromatosis, all available pathological specimens and sequential imaging studies were closely reexamined, respectively, by an experienced neuropathologist (B.W.S.) and an experienced musculoskeletal radiologist (K.K.A.).
With respect to serial MR imaging, in instances in which the NMC included areas of signal intensity different from that of muscle and/or nerve, further quantitative measures were made to confirm the differences. Using standard workstation tools, small regions of interest were generated: 1) the area within the NMC with a different signal intensity; 2) an area representative of the main signal intensity of the NMC; 3) an area of normal muscle (control); and 4) an area of normal nerve (control). A mean value for signal intensity of the pixels enclosed by each region of interest was given by the program. Because absolute signal intensity measurements can vary depending on many factors (for example, position of the tissues in relation to the surface coil, amplifier gain of the image reconstruction circuitry), relative signal intensities were studied. For each case, ratios were calculated comparing the signal intensity of the NMC (area with a "different" signal intensity and area representative of the lesion) with those of either normal muscle or nerve. In addition, ratios between the signal intensity of the "different area" and that of the rest of the NMC were calculated in each case.
Cases Reported in the Literature
To explore the possible etiology for the development of aggressive fibromatosis in patients with NMC and the possible connections between these 2 pathologies, all cases of NMC reported in the literature were reviewed. We searched MEDLINE databases using the terms "neuromuscular choristoma," "neuromuscular hamartomas," "benign triton tumor," and "nerve rhabdomyoma," and cross-referenced all relevant articles to retrieve the greatest possible number of NMC cases. All pathological descriptions and histological samples were reviewed by a neuropathologist (B.W.S.). Cases were included only if sufficient pathological descriptions and/or histological images clearly supported the diagnosis of NMC. The descriptive and/or imaging evidence of largely matureappearing muscle fibers and peripheral nerve fibers in which myocytes were intimately associated with nerve fascicles and were at least in part endoneurial was required for inclusion of a case in the analysis. In all included cases, patient demographic characteristics, presenting symptoms, imaging data, surgical treatment, and available follow-up information were reviewed. All provided MR imaging images were examined for the presence of areas of signal intensity different from the signal intensity of muscle and/or nerve by the same musculoskeletal radiologist (K.K.A.).
Results
Cases Encountered in our Institution
We identified 10 patients in whom a diagnosis of NMC was established at our institution between 1992 and 2010, 4 of whom had definite or suspected aggressive fibromatosis. One of these 4 cases was previously reported 29 and was revisited given the development of aggressive fibromatosis at recent follow-up. An additional case reviewed at our institution with the diagnosis of both NMC and aggressive fibromatosis is included in the literature review section since it was reported previously.
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Of the 6 patients with NMC who did not develop aggressive fibromatosis, only 1 patient had adequate followup: a 12-year-old girl, who underwent a subtotal resection of a brachial plexus mass, with no evidence of progression of the residual mass on serial MR imaging studies performed over a 10-year period. One other patient had been treated at our institution; the NMC was of the buccal area, but only 1-year follow-up was available. The other 4 patients were treated at outside institutions; only the pathological specimens (NMC of the forehead, neck, pharyngeal, and unknown site) were reviewed at our institution, and no clinical follow-ups were available.
The 4 patients with NMC and aggressive fibromatosis (Table 1) included 2 males and 2 females presenting between the ages of 5 and 42 years, with the lesions involving the sciatic nerve (3 cases) and brachial plexus (1 case). All presented with a neuropathy or plexopathy confirmed by electrodiagnostic studies, and 3 had secondary musculoskeletal changes (foot deformity [2 cases] and/or extremity asymmetry [2 cases]). The 2 adult patients also presented with progressive pain. The MR imaging studies showed fusiform enlargement of the involved nerve(s). The diagnosis of NMC was made on the basis of either open biopsy (3 cases) or CT-guided biopsy (1 case). Between 4 months and 8 years postoperatively, all patients presented with a new enlarging mass in the vicinity of the NMC and the biopsy site. Biopsy revealed aggressive fibromatosis in 3 of the 4 patients; in the other patient, although imaging was consistent with aggressive fibromatosis, the limited biopsy failed to confirm the diagnosis. Management varied and consisted of observation in 2 cases, chemotherapy followed by resection in 1 case, and resection followed by radiotherapy at recurrence in 1 case. In all patients, the aggressive fibromatosis recurred (2 cases) or progressed (2 cases). enlarging mass on serial MRI over 16 mos discrete from brachial plexus NMC, which has remained stable * Bx = biopsy; chemo = chemotherapy; deter = deterioration; distrib = distribution; FU = follow-up; incl = including; LE = lower extremity; msk = musculoskeletal; neurol = neurological; recur = recurrence; UE = upper extremity.
Retrospective Pathology Review. In all patients, the initial pathology was that of NMC without evidence of fibromatosis ( Fig. 1) . However, all lesions were associated with surrounding densely collagenous areas of low cellularity. These were not distributed homogeneously within the specimens. At recurrence, in 3 of the 4 lesions (Cases 1, 2, and 3), the histology of the mass was that of aggressive fibromatosis (Fig. 1) . In 2 cases (Cases 1 and 3), the aggressive fibromatosis was histologically in close association with or spatially related to the NMC. This relationship was not evident on the specimen obtained in the limited CT-guided biopsy performed in Case 2. In the last instance (Case 4), the biopsy revealed only hypocellular collagenous tissue, perhaps not representative of the imaging abnormality.
Retrospective Imaging Review. In 3 of our 4 patients (Cases 1, 2, and 4) the initial MR imaging study showed areas with signal intensities different from and significantly lower than that of muscle, nerve, and other portions of the NMC. These areas were located within and/ or at the periphery of the NMC (Figs. 2-4). Qualitative differences in signal intensity were confirmed quantitatively by calculating ratios of relative signal comparing the area of interest with muscle, nerve and the rest of the NMC. On serial MR imaging studies available for Cases 1, 2, and 4, the areas with a different signal intensity had persisted and the difference was again confirmed quantitatively with relative signal intensity ratios. When all examinations were considered, the area with a lower signal intensity was significantly different from muscle, nerve, and the rest of the NMC (p < 0.003). In 1 case (Case 3), the initial imaging study was unavailable. However, in limited images available from a subsequent MR imaging study, similar signal intensities different from those of muscle, nerve, and other areas of the NMC were seen at the time of aggressive fibromatosis development (Fig. 5) . Based on available serial MR imaging studies in Cases 1, 2, and 4, aggressive fibromatosis seems to form in the vicinity of, or even originate within, these persistent regions of lower intensity.
Cases Reported in the Literature
With the search criteria, 50 articles referring to 66 cases of NMC were found. After review, 48 cases were excluded for various reasons: 1) the diagnosis of NMC could not be clearly confirmed because of the lack of pathological information; [9] [10] [11] 13, 24, 25, 32, 35, 45 2) most cases involving cranial nerves were either difficult to assess because of limited information or seemed to represent a different pathology consisting of muscular and neural elements with a different relationship and often combined with the presence of lipomatous cells; These patients with NMC presented mostly in early childhood (before the age of 2 in 10 of 18 cases), with only 4 patients presenting in adulthood; the mean age of presentation was 9.75 years (range birth to 68 years). Both sexes were affected, with 11 cases involving female patients and 7 involving male patients being reported. Major peripheral nerves were most frequently involved (8 brachial plexus nerves, 6 sciatic nerves), but lesions were also reported to occur in intercostal nerves, 5 the vaginal wall, 2 the face, 42 and arytenoid submuscosa. 12 Although brachial plexus lesions could involve multiple nerves, all lesions were solitary except for 1 case in which there were 2 dis- tinct masses along the same nerve. 36 Nine of the patients presented initially only with a mass. The case involving 2 masses along the same nerve was identified at autopsy. 36 In all the other cases, the patients had symptoms related to mass effect-stridor (in 1 patient), pain (in 2 patients), sensory and/or motor deficits (in 3 patients), and/or secondary musculoskeletal deformity (in 2 patients). In all cases except the one found at autopsy, the patients underwent surgery. The initial surgery was biopsy in 4 cases, partial resection in 7, and complete resection in 6.
Recurrences and Occurrence of Aggressive Fibromatosis.
In the literature, patients with NMC were followed up for a mean of 2.9 years (median 2.75 years), with the duration of follow-up ranging from the immediate postoperative period to 9 years postoperatively. Of the 18 patients, 6 developed a recurrent mass. Only 1 patient with a recurrent mass 42 did not have evidence of aggressive fibromatosis: the recurrent or possibly residual tumor was seen on imaging 1 month postoperatively and remained stable over the following 2.5 years. The other 5 cases with a recurrent mass either clearly (2 cases) or probably (3 cases) developed aggressive fibromatosis. In 1 case, 8 a recurrence noted soon postoperatively remained stable for 4 years. The area was then reexplored, but because the mass was involving the median nerve, only a biopsy was performed. The biopsy showed dense fibrous tissue, which potentially could have represented aggressive fibromatosis. The mass remained stable for the subsequent 2 years of follow-up. In the 3 other patients, 4, 5, 33 the mass recurred after biopsy (1 year), 4 resection (1 year), 5 or partial resection (1 month). 33 One or more additional resections were performed in each case, but the masses kept recurring, ultimately requiring amputation. In all 3 cases, pathology specimens revealed NMC and aggressive fibromatosis. In 2 of the cases, 4,5 aggressive fibromatosis was initially seen (although not diagnosed per 
. Magnetic resonance images obtained preoperatively (A-C) and 5 years after CT-guided biopsy (D-F). A:
Axial T2-weighted image with fat suppression at the level of the acetabulum shows a mass (arrow) with heterogeneous but overall low signal. An area of lower signal consistent with fibromatosis (arrowhead) is seen at the periphery of the mass encasing the sciatic nerve. B: Axial T1-weighted image at the same level shows the mass with low signal extending into the sciatic notch. Note atrophy in the gluteus maximus muscle (plus signs). C: Axial Gd-enhanced T1-weighted image with fat suppression shows enhancement of the mass (arrows) with some focal, nonenhancing low signal areas. The enhancement within the gluteus maximus muscle is related to subacute denervation change. D: Axial T1-weighted image at the level of the ischial tuberosity shows enlargement the heterogeneously low signal mass, which is now causing very significant mass effect on the adjacent gluteus maximus muscle (plus signs). E: Axial T1-weighted image obtained slightly superior to D showing the increase in size of the mass as well as further intrapelvic extension. Again noted are sheetlike areas of low signal representing fibrous tissue (arrowheads). Total hip arthroplasty causes artifact on this image. F: Coronal T1-weighted image shows the full extent of the mass through the sciatic notch as well as the prominent muscular atrophy.
se in one 4 ); in these 2 cases, NMC was only diagnosed at amputation 4 or retrospectively. 5 In the other case, 33 NMC was initially diagnosed, and aggressive fibromatosis was noted at recurrence. One additional patient 1 could also be considered to have had a recurrent mass and possible aggressive fibromatosis: a previous partial resection of a mass in the same area, likely of the same pathological type, was done 35 years earlier when the patient was 7 months old. The initial pathological examination revealed dense fibrous tissue interdigitating with skeletal muscle; 35 years later, histological examination revealed neuromuscular elements admixed with dense fibrous tissue.
Pathology and Imaging Review. In all included cases, the pathological findings were consistent with NMC. The reports described nerve fibers and mature skeletal muscle. However, in 11 of the 18 cases the report also mentioned a component of increased, dense fibrous tissue, bands thereof, or a collagenous matrix. [1] [2] [3] [4] [5] 8, 20, 21, 30 Magnetic resonance images provided in 6 of the 18 cases of NMC 3, 4, 20, 21, 33 all exhibited areas of very low signal intensity different from the signal intensity of muscle and/ or nerve. These regions were compatible with the usual MR imaging appearance of fibrous tissue.
Discussion
Despite various theories regarding the pathogenesis of NMC, its true nature and the mechanisms underlying its development remain to be established. Little is known of its natural history and evolution over time. Our report emphasizes the occurrence of aggressive fibromatosis in NMC. A potential etiological relationship has only been briefly mentioned. 20 Its basis remains elusive. Questions remaining include: 1) Is the occurrence of aggressive fibromatosis in patients with NMC a coincidence? 2) Is the development of aggressive fibromatosis in these patients related to surgery? 3) Can the development of aggressive fibromatosis be related to other factors? and 4) Does a direct relationship exist between NMC and the development of aggressive fibromatosis?
Is the Occurrence of Aggressive Fibromatosis in Patients With NMC a Coincidence?
The occurrence of aggressive fibromatosis in patients with NMC seems too high to be a coincidence. If the cases encountered at our institution (10 cases) and the cases reported in the literature (18 cases) are combined, at least 5 patients had aggressive fibromatosis (Cases 1-3 and 2 cases reported in the literature 5, 33 ), and 4 others likely did (Case 4 and 3 cases reported in the literature 1, 4, 8 ). This means that aggressive fibromatosis occurred in 18% to 32% (5/28 to 9/28) of patients. In the context of a short follow-up for the cases reported in the literature (mean of 2.9 years) and the delayed development of fibromatosis in some patients (up to 8 years in Case 1), it is possible that the occurrence of fibromatosis in these patients may be even higher. Within the literature, 48 cases have been excluded, largely because these cases were not clearly NMC and may have represented other pathological processes. However, even if these cases were all considered to be NMC, and all did not develop aggressive fibromatosis, aggressive fibromatosis would have still occurred in 7% to 12% (5/76 to 9/76) of patients. Since both lesions are rare, it is fair to say that the development of aggressive fibromatosis in NMC patients is more than a coincidence.
Is the Development of Aggressive Fibromatosis in These Patients Related to Surgery?
The etiology of aggressive fibromatosis is poorly understood, but the development is thought to be influenced by physical factors such as trauma and surgery, 28, 44 especially in patients with familial adenomatous polyposis.
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In some of our patients, surgery seems to be an initiating event. Clearly, in 3 of our cases (Cases 1-3) and in 2 of the cases described in the literature, 4,33 surgery preceded and perhaps promoted the development of the fibromatosis. However, fibromatosis was present in one of the cases at the time of the initial surgery.
5 Therefore, surgery may frequently be an initiating factor, but other mechanisms are also likely involved.
Can the Development of Aggressive Fibromatosis in These Patients be Related to Other Factors?
Hormonal factors have been reported to influence the pathogenesis of fibromatosis. For example, abdominal fibromatosis mainly occurs in female patients during or after pregnancy. 44 In patients with NMC, fibromatosis developed in females (6 cases) as well as in males (3 cases), and mainly in childhood (6 cases). No endocrine abnormality has been reported, but it is difficult to eliminate possible hormonal influences. In the literature, fibromatosis has also been associated with both Gardner syndrome and familial adenomatous polyposis, thus suggesting a genetic predisposition for the development of such tumors. In patients with NMC, a genetic susceptibility to the development of aggressive fibromatosis is also possible. However, the fact that all aggressive fibromatosis develops in the area of the NMC suggests that a genetic predisposition is unlikely to be the single or dominant factor leading to their development.
Does a Direct Relationship Exist Between the NMC and Development of Aggressive Fibromatosis?
In patients with NMC, we believe that there is a direct relationship between the occurrence of aggressive fibromatosis and NMC, perhaps in addition to other factors discussed above. In support of this notion is the observation that all patients who developed aggressive fibromatosis have done so at the site of their NMC. Moreover, histological examination of the pathological specimens showed the aggressive fibromatosis to be histologically in close spatial association to the NMC elements in 2 of our cases and in 2 previously reported cases.
4,5
Our pathological review has shown that NMC is, even initially, somewhat heterogeneous in makeup. In addition to the variable combination of nerve and skeletal muscle fibers, most lesions, both at our institution and in the literature, possess variable amounts of fibrous and/or collagenous tissue. The heterogeneity of NMC, even at initial presentation, is confirmed on imaging by the presence or emergence of signal intensities differing from those of muscle and/or nerve. Both our cases and the available images of published cases show this signal heterogeneity, possibly reflecting the presence of fibrous tissue, even at an early stage. In our cases, serial imaging suggests that the aggressive fibromatosis develops in relation to these areas of signaling. It appears that fibromatosis develops within or at the periphery of the NMC at an early stage and the process of fibrous tissue proliferation is activated by a surgical procedure. This is not to say that simple chronic fibrosis foreshadows the development of fibromatosis. Lastly, the absence of fibromatosis at often limited initial biopsies does not preclude its presence. In that quite frequently only a fascicular biopsy is taken, a fibromatosis component may well have been unsampled.
Various theories regarding the etiology of NMC could be consistent with a direct relationship between NMC and the development of aggressive fibromatosis. Orlandi 36 suggested that NMC results from the entrapment of muscle (or mesenchymal cells) into the substance of developing nerves; other mesenchymal cells, such as fibroblasts, could also be incorporated. Masson 31 suggested that neuroectoderm was capable of mesenchymal differentiation, specifically skeletal muscle. Even arachnoidal cells comprising the leptomeninges are, in part, neuroectodermal in derivation. 50 This mechanism could explain the development of NMC-associated fibromatosis in that differentiation of primitive cells toward fibroblasts may also be possible. Finally, it has been suggested that the development of fibrosis may be related to degeneration of neural components and thereafter degeneration of the skeletal muscle component due to loss of trophic stimuli. 20 This process could lead, depending upon the effect of other factors, to spontaneous regression of NMC or to the development of aggressive fibromatosis. Just which mechanism is responsible for the development of NMC and its association with aggressive fibromatosis is currently unknown, but evidence suggests that various mechanisms likely facilitate the process.
Conclusions
The present study confirms that aggressive fibromatosis in patients with NMC has been underreported. Pathological and imaging evidence suggests that a direct relationship exists between NMC and the development of aggressive fibromatosis. Further careful follow-up study may help determine the best preventive and therapeutic approaches to aggressive fibromatosis.
Addendum
Since the submission of this manuscript, the senior author has treated yet another patient with NMC unassociated with aggressive fibromatosis (desmoid tumor). This 14-year-old boy had a long history of progressive sciatic neuropathy with leg-length discrepancy, a cavus foot, and an enlarged sciatic nerve, features reminiscent of a previous patient described in an earlier publication. 29 The diagnosis of NMC, suspected based on clinical history and physical examination, was supported by imaging findings. The MR imaging abnormality extended within the sciatic nerve from the proximal thigh through the sciatic notch to involve the S-1 nerve, and the lesion had both adipose and soft tissue elements. Collectively the features suggested NMC, rather than lipomatosis of nerve (fibrolipomatous hamartoma), in that 1) undergrowth of the affected limb, rather than the overgrowth often seen in patients with lipomatosis of nerve, as well as 2) relative paucity of intralesional adipose tissue on MR imaging, were noted. Intraoperative stimulation of the tibial and peroneal divisions of the sciatic nerve and of a hamstring branch resulted in contraction of the nerve(s) (Video 1), thus confirming the diagnosis of NMC in which myocytes are present within nerve. A fascicular biopsy confirmed the diagnosis of NMC unassociated with aggressive fibromatosis. The specimen, a hamstring branch, consisted of a grossly brown nerve-the color being a reflection of the muscle content. Histologically, the mature muscle fibers were intimately admixed with nerve fibers. Long-term follow-up will be necessary in order to detect the possible development of fibromatosis, which may occur many years after diagnosis of an NMC. Based on our experience with this condition, we anticipate that the diagnosis of NMC can be suggested by careful interpretation of MR images and correlation with the clinical information. Establishing the diagnosis with a high degree of confidence using imaging criteria may eliminate the risk of surgery inducing a fibromatosis.
Click here to view the video with Windows Media Player. Click here to view the video with Quicktime.
